Results 221 to 227 of about 5,291 (227)

Use of mechlorethamine gel in patients diagnosed with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL): “Real-world” experience from the Prospective Observational Study (PROVe)

Journal of American Academy of Dermatology, 2018
L. Geskin, J. Guitart, Ellen J. Kim, G. Sharma, Carol Zhao, B. Rengarajan   +5 more
semanticscholar   +1 more source

Photo-triggered fluorescent theranostic prodrugs as DNA alkylating agents for mechlorethamine release and spatiotemporal monitoring.

Organic and biomolecular chemistry, 2015
Yanting Cao, Rong Pan, Weimin Xuan, Yongyi Wei, Kejian Liu, Jiahong Zhou, Wei Wang   +6 more
semanticscholar   +1 more source

Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.

Veterinary and Comparative Oncology, 2015
A. Back, S. Schleis, O. Smrkovski, J. Lee, Annette N. Smith, J. Phillips   +5 more
semanticscholar   +1 more source

Carcinogenicity of topical mechlorethamine in mice

Journal of the American Academy of Dermatology, 1992
openaire   +1 more source

CARCINOSTATIC PROPERTIES OF MECHLORETHAMINE OXIDE.

Archives internationales de pharmacodynamie et de therapie, 1996
T, DASGUPTA, G, PIETRA, V, SCORTECCI, J, SICE   +3 more
openaire   +1 more source

Pharmaceutics: mechlorethamine (nitrogen mustard).

Cancer nursing, 1981
openaire   +1 more source

Mechlorethamine Hydrochloride Therapy for Systemic Lupus Nephropathy

JAMA, 1963
openaire   +1 more source